Home > Insider Trading > Filing (0001209191-22-020160)

Filing Details

Accession Number:: 0001209191-22-020160
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-18 20:12:36
Reporting Period:: 2022-03-16

Accepted Time:: 2022-03-18 20:12:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1016835	B Rory Riggs	C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-03-16	20,686	$58.72	205,984	No	4	S	Indirect	Held by New Ventures I, LLC
Common Stock	Disposition	2022-03-16	43,848	$59.53	162,136	No	4	S	Indirect	Held by New Ventures I, LLC
Common Stock	Disposition	2022-03-17	26,587	$59.99	135,549	No	4	S	Indirect	Held by New Ventures I, LLC
Common Stock	Disposition	2022-03-17	114,912	$60.41	20,637	No	4	S	Indirect	Held by New Ventures I, LLC
Common Stock	Disposition	2022-03-18	4,901	$60.63	15,736	No	4	S	Indirect	Held by New Ventures I, LLC
Common Stock	Disposition	2022-03-18	15,736	$61.35	0	No	4	S	Indirect	Held by New Ventures I, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by New Ventures I, LLC
No	4	S	Indirect	Held by New Ventures I, LLC
No	4	S	Indirect	Held by New Ventures I, LLC
No	4	S	Indirect	Held by New Ventures I, LLC
No	4	S	Indirect	Held by New Ventures I, LLC
No	4	S	Indirect	Held by New Ventures I, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	76,815	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.21 to $60.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.21 to $60.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.13 to $61.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.13 to $61.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.